CVS Deal for Omnicare Seen Avoiding PharMerica Antitrust Stumble Bloomberg-1 hour ago

CVS Health Corp (CVS) - Investment Analysts' Weekly Ratings ...

Dakota Financial News-10 hours ago

The Pharmacy Services segment was benefited from growth in specialty pharmacy business while the Retail Pharmacy segment gained from increased same ...

Led by CEO Merlo, CVS charts bold course forward
The Providence Journal-14 hours ago

CVS Deal for Omnicare Seen Avoiding PharMerica Antitrust Stumble
Bloomberg-1 hour ago

Morningstar Assigns "BBB+" Credit Rating to CVS Health Corp (CVS)
The Legacy-5 hours ago

CVS and Omnicare in $12bn deal
Financier Worldwide-5 hours ago

Explore in depth  (9 more articles)